a developer of small molecule drugs
Industry Biotechnology
A.I.dvisor tells us that EPIX and ASMB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPIX and ASMB's prices will move in lockstep.
Ticker / NAME | Correlation To EPIX | 1D Price Change % | ||
---|---|---|---|---|
EPIX | 100% | +6.08% | ||
ASMB - EPIX | 24% Poorly correlated | -2.64% | ||
NKTX - EPIX | 24% Poorly correlated | -3.01% | ||
RLYB - EPIX | 24% Poorly correlated | -4.35% | ||
ACLX - EPIX | 23% Poorly correlated | -3.81% | ||
ACET - EPIX | 22% Poorly correlated | +2.05% | ||
More |
Ticker / NAME | Correlation To EPIX | 1D Price Change % |
---|---|---|
EPIX | 100% | +6.08% |
north america theme (189 stocks) | 14% Poorly correlated | -0.16% |
pharmaceuticals theme (167 stocks) | 9% Poorly correlated | +0.82% |
small molecule theme (11 stocks) | 5% Poorly correlated | -1.27% |